About Plabeltech
Plabeltech is a company based in Bhopal (India) founded in 2018 by Vishal Rai. Plabeltech offers products and services including MS Sensitivity Booster-PS1, MS Sensitivity Booster-PD1, MS Sensitivity Booster-BC1, and Gly-Tag Purification Resin. Plabeltech operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Bhopal, India
- Founders Vishal Rai
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Plabeltech Private Limited
- Date of Incorporation 08 Mar, 2018
- Jurisdiction Bhopal, Madhya Pradesh, India
-
Annual Revenue
$21.51 K (USD)1120.47as on Mar 31, 2022
-
Net Profit
$17.69 K (USD)4841.37as on Mar 31, 2022
-
EBITDA
-$237.32 (USD)-29.06as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Plabeltech
Plabeltech offers a comprehensive portfolio of products and services, including MS Sensitivity Booster-PS1, MS Sensitivity Booster-PD1, MS Sensitivity Booster-BC1, and Gly-Tag Purification Resin.
Enhances peptide detection in mass spectrometry analysis.
Boosts protein detection for accurate spectrometry results.
Improves biomolecule sensitivity in mass spectrometry.
Facilitates efficient purification of tagged proteins.
Funding Insights of Plabeltech
Detailed funding history for Plabeltech
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Plabeltech
Investment portfolio details for Plabeltech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Plabeltech
Detailed financials for Plabeltech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Plabeltech Comparisons
Peer comparison for Plabeltech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Plabeltech
Plabeltech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
Detailed competitors of Plabeltech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Plabeltech
Complete news archive for Plabeltech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Plabeltech
Plabeltech was founded in 2018.
Plabeltech is headquartered in Bhopal, India. It is registered at Bhopal, Madhya Pradesh, India.
Annual revenue of Plabeltech is $21.51K as on Mar 31, 2022.
Plabeltech is the provider of products and services for protein engineering. The company delivers labeling of proteins and antibodies with the probe of interest. They also developed the in-house kit for multifold enhancement in the sensitivity of peptide detection (MS), peptide mapping (MS), and their fragments (MS-MS). They also provide product for purification and isolation of proteins with Gly residue at the N-terminus.
Plabeltech's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Plabeltech offers MS Sensitivity Booster-PS1, MS Sensitivity Booster-PD1, MS Sensitivity Booster-BC1, and Gly-Tag Purification Resin.